With over 35 nationalities and a range of backgrounds represented in our Benevolent team, we aim to build an inclusive environment where our people can bring their authentic selves to work, be respected for who they are and the exceptional work they do. We welcome and actively encourage applications from all sections of society and are committed to offering equal employment opportunities regardless of sex, race, religion or belief, ethnic or national origin, marital, domestic or civil partnership status, sexual orientation, gender identity, parental status, disability, age, citizenship, or any other basis. We see our diversity as an asset as we tackle challenging problems that bridge the gap between drug discovery and technology.
We would like to hear from applicants with a keen interest in data landscaping and acquisition as well as data management. You will find yourself working as part of a cross-functional team supporting the application of BenevolentAI’s data integration, target identification and precision medicine activities to our drug discovery programs.
The Portfolio Delivery team helps ensure our internal analysis tools and algorithms, as well as our data, are used to their fullest extent in our drug discovery programs. It helps structure our drug discovery workflows and devises new approaches to help answer biological questions raised by our various disease programs, for example to help identify and validate potential drug targets or support the identification of biomarkers.
As a Senior Data Acquisition Specialist in the team, you will contribute to this challenge by providing support to our drug discovery teams in the identification of relevant cohorts or datasets, in the creation of strong links with potential collaborators and in the application of FAIR (Findable, Accessible, Interoperable, and Reusable) principles.
We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey. If that sounds like a fit for you, hit the apply button and join us.
BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers a growing in-house pipeline of 13 named drug programmes and over 10 exploratory programmes, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.
Our team will only contact you from the domain @benevolent.ai. If you receive a suspicious contact request, please email firstname.lastname@example.org. Thank you.